1. Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening
   Jeeyun Lee et al, 2015, Oncotarget CrossRef
2. ALK alteration is a frequent event in aggressive breast cancers
   Abdul K. Siraj et al, 2015, Breast Cancer Research CrossRef
3. Insufficient antibody validation challenges oestrogen receptor beta research
   Sandra Andersson et al, 2017, Nature Communications CrossRef
4. Ditercalinium chloride: A potential inhibitor targeting recurrent in frame COMMD10-AP3S1 fusions in CRCs
   Sandhya Rai et al, 2023, Gene Reports CrossRef